NCT05438147 is a NA clinical trial of CT-100 DiNaMo in Multiple Sclerosis, sponsored by Click Therapeutics, Inc..

Who is sponsoring NCT05438147?

NCT05438147 is sponsored by Click Therapeutics, Inc..

What drugs are being tested in NCT05438147?

Interventions in NCT05438147: CT-100 DiNaMo, Care-as-Usual.

What condition does NCT05438147 study?

NCT05438147 studies Multiple Sclerosis, Mild Cognitive Impairment, Cancer.

Is NCT05438147 still recruiting?

NCT05438147 is currently completed. Last updated 26 April 2023.

Last reviewed 2023-04-26 · How we verify

NCT05438147

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Completed NA Last updated 26 April 2023

What this trial tests

NA trial testing CT-100 DiNaMo in Multiple Sclerosis in 114 participants. Completed in 6 September 2022.

Timeline

13 May 2022

Primary endpoint
6 September 2022

6 September 2022

Quick facts

Lead sponsor	Click Therapeutics, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	114
Start date	13 May 2022
Primary completion	6 September 2022
Estimated completion	6 September 2022
Sites	1 location across United States

Drugs / interventions tested

CT-100 DiNaMo
Care-as-Usual

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →
Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Cancer — all drugs for Cancer →

Sponsor

Click Therapeutics, Inc.

Who can join

Adults 22 to 75, any sex, with Multiple Sclerosis or Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CT-100 is a platform that provides an interactive, software based therapeutic component that may be used as part of a multimodal treatment in supplementary or standalone prescription or nonprescription software-based digital therapeutics (PDT/DTx), being developed by Click Therapeutics, Inc.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Digital therapeutics in the clinic.
Phan P, Mitragotri S, Zhao Z. · · 2023 · cited 39× · PMID 37476062 · DOI 10.1002/btm2.10536

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Click Therapeutics, Inc. trials

Trials by the same sponsor.

NCT06486948 — An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-1 · NA · completed
NCT06275659 — An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis · NA · completed
NCT06136923 — An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer · NA · completed
NCT06136936 — A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia · NA · completed
NCT06067984 — An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Sc · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05438147 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Click Therapeutics, Inc.
Last refreshed: 26 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05438147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing